论文部分内容阅读
自甲胎蛋白(AFP)作为诊断原发性肝癌(下称肝癌)的手段以来,已有不少无症状、体征的肿瘤直径≤5cm的小肝癌被发现,可以较早期进行手术切除,使肝癌术后的生存率有较大的提高,降低了手术死亡率,是肝癌诊断和治疗方面的一个突破。小肝癌经手术切除后,5年生存率可达60％。但是,从小肝癌根治术后随访发现,存在肝癌再发的问题,严重影响小肝癌的预后,为此,将我院从
Since alpha-fetoprotein (AFP) has been used as a means for diagnosing primary liver cancer (hereinafter referred to as liver cancer), there have been many asymptomatic and physical signs of small hepatocellular carcinoma with a tumor diameter of ≤ 5 cm, which can be surgically removed earlier to make liver cancer more difficult. The survival rate after surgery has been greatly improved, which reduces the operative mortality and is a breakthrough in the diagnosis and treatment of liver cancer. After the small hepatocellular carcinoma has been surgically removed, the 5-year survival rate can reach 60%. However, after follow-up after radical resection of small hepatocellular carcinoma, there was a problem of recurrence of liver cancer, which seriously affected the prognosis of small hepatocellular carcinoma.